Aurinia Pharmaceuticals, Inc. (AUPH) CEO Peter Greenleaf on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/15/20
Aurinia Pharmaceuticals' (AUPH) CEO Peter Greenleaf on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 03/06/20
Do Options Traders Know Something About Aurinia (AUPH) Stock We Don't?Zacks Investment Research • 03/04/20
Options Traders Expect Huge Moves in Aurinia Pharmaceuticals (AUPH) StockZacks Investment Research • 01/23/20
Aurinia's Successful Study In Lupus Nephritis Changes The Scope Of Treatment Options For PatientsSeeking Alpha • 12/06/19
Aurinia's Stock More Than Doubles On Results From Pivotal Trial Of Voclosporin In Lupus NephritisBenzinga • 12/05/19
Shares of biotech Aurinia more than double in one day after positive data for Lupus drugCNBC • 12/05/19
Aurinia Pharmaceuticals surges more than 110%, after positive trial for lupus-related drugMarket Watch • 12/04/19
Aurinia Pharmaceuticals, Inc.'s (AUPH) CEO Peter Greenleaf on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/15/19
Aurinia Pharmaceuticals (AUPH) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseZacks Investment Research • 11/07/19